After much anticipation, the CEREC 25th Anniversary Celebration date and location have been announced. Featuring a speaker line-up rivaling any event in the dental industry, celebrity entertainment including a special performance by 5-time Emmy winning comedian and actor Dennis Miller, and the C25 Party at PURE, the event is sure to “wow” attendees. The CEREC 25th
Anniversary Celebration, commemorating Sirona’s 25 years of CAD/CAM leadership and success, will be held August 26 – 28, 2010 at Caesars Palace in Las Vegas.  The Celebration will provide dental professionals with valuable CAD/CAM education, as well as many opportunities to meet and mingle with
thousands of colleagues. The event will also be a “can’t miss” opportunity for any dentists considering integrating CAD/CAM or digital impressions into their practice.

The Celebration will offer up to 18 hours of CE credit with courses from the top names in dentistry. Doctors will want to bring their staff as courses will provide valuable material for all dental team members. There will
be activities of interest to Laboratory CAD/CAM users as well, with renowned dental technicians speaking.  Scheduled speakers at this time include the inventor of CEREC, Prof. Dr. Werner Mörmann, Dr. Frank Spear, Dr. Gordon Christensen, Dr. Rella Christensen, Mr. Imtiaz Manji, Dr. James Klim, Dr. Mark Morin, Dr. Sam Puri, Dr. Mark Hyman, Mr. Fred Joyal, Dr. Dennis Fasbinder, and Mr. Matt Roberts, CDT.  Additional speakers will be announced in the coming weeks.  For more information and to take advantage of discounted tuition please visit www.CEREC25.com.  Commemorate the past, Celebrate the present, and Create the future of dental CAD/CAM at the CEREC 25th Anniversary Celebration!

In its entirety, the iLase is about the size of a large pen, and has five full watts of power. The iLase, along with two batteries, can be transported in a carrying case the size of an eye glasses case and is the first completely self-contained, hand-held dental laser that includes the laser, user interface, battery power, and controls in a single, integrated handpiece with no foot pedals or cords attached.

The iLase is also the only dental laser controlled by a patent-pending finger switch on the laser handpiece, which uniquely eliminates the need for a foot control pedal. It also uses BIOLASE’s proprietary ComfortPulse(TM) control that lets clinicians adjust the laser for maximum patient comfort and cutting speed.

“The iLase is like no other instrument I have ever used,” said David Eshom, D.D.S., a general cosmetic dentist based in San Diego. “It looks great and works wonderfully. You don’t have to look for a foot pedal as you are trying to reach different parts of the mouth. You just point and shoot.”

BIOLASE Chief Executive Officer David M. Mulder said, “BIOLASE is the market leader in dental lasers. Now with the iLase, we have the best entry-level laser, and the only truly personal laser in the world for both hygienists and dentists. You can literally put everything you need in your pocket for hours of use. This new laser is a revolutionary breakthrough. It changes everything. We have found many dentists and hygienists, who have not used lasers before, are all suddenly clamoring for a chance to try and own an iLase in offices where they were being tested. We have also found that after learning about the iLase, there is a renewed interest in finding out more about the total diode solution in the ezlase(TM) and the best soft tissue (and hard tissue) lasers in the world, the Waterlase(R) line.

“A clinician can easily carry all the components of the laser in one hand and you don’t have to plug it into a power outlet,” Mulder added. “That’s why we call it the first ‘personal’ laser. There is nothing on the dental laser market like it, and we expect the device to significantly improve workflow in the dental suite, by making it easier than ever for any dentist and hygienist to bring laser technology to any patient.”

Craig H. Rubinoff, D.D.S., M.S., a periodontist with Rancho Bernardo Periodontics, said the iLase “feels very balanced in my hand. It feels very ergonomic. We can do everything that can be done with other soft-tissue lasers with this — and not having the foot pedal is amazing.”

Clearance of the iLase by the U.S. Food and Drug Administration (FDA) is pending. Once cleared for the market, the iLase, including handpiece, shroud, batteries, and all standard accessories will be offered at a very competitive price.

The iLase has 10 completely pre-set soft tissue and hygiene procedures at the simple push of a button, including gingivectomy, troughing for crown procedures and sulcular debridement, and a procedure for cleaning between gums and teeth for the treatment of periodontal disease. The iLase and the ezlase both share a comprehensive set of 25 FDA-cleared soft tissue and hygiene procedures. For a full diode solution, the ezlase goes beyond the basic iLase with 20-minute teeth whitening and FDA-cleared pain relief functions.

Mulder continued, “iLase represents a new category for both BIOLASE and for the industry. A self-contained laser tool is something our customers have asked for and we are pleased to be the first to deliver it. No other dental laser company devotes anywhere near the resources we do to Clinical R&D and Engineering. We are looking forward to rolling out iLase with Henry Schein, Inc. (NASDAQ: HSIC), and our other global distribution partners, as soon as it receives regulatory clearance.”

BIOLASE will be demonstrating the iLase at its booth #4619 throughout the Chicago show. The iLase is also being previewed to the media at 10:00 a.m. CST today at McCormick Place, West Building, Room W475A, 2301 S. Indiana Avenue, Chicago, IL 60616. A preview video of the iLase can also be viewed at www.biolase.com.

For more information on the iLase, contact BIOLASE at 1-877-670-4767.

The conference, supported by the Emirates Medical Association’s Dental Society, will bring together leading academics and clinicians engaged in all areas of dentistry. They will provide a review of the current evidence-based status of various areas relevant to dentistry, as well as in current trends, clinical developments and techniques. Eminent speakers will include Professor Malcolm Harris, Director of Research at the Postgraduate Dental Educational Unit, University of Warwick Medical School, and Dr. Patrick J. Byrne, Dean, and Dr. R. Gerard Cleary, Immediate Past Vice-Dean, of RCSI’s Faculty of Dentistry. A past president of the Irish Dental Association is also among the speakers.

This conference is intended to be a step towards AUST’s goal of advancing the field of dentistry and leading the way in better patient management. It is intended that the conference should represent the cutting edge in oral care for patients and should therefore be of particular interest to oral healthcare professionals aspiring to provide enlightened, up-to-date and comprehensive care. The event will also provide an opportunity for participants to exchange ideas and share experience, thus providing mutual support, education and inspiration.

By Sandra Shagat February 16, 2010 Category: Health Sciences, Research

Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fight.

The good news is that there may soon be a new weapon in the battle against the so-called “worst” cancer — cancer of the pancreas. A multidisciplinary group of investigators from the UCLA School of Dentistry, the David Geffen School of Medicine at UCLA, the UCLA School of Public Health and UCLA’s Jonsson Comprehensive Cancer Center has demonstrated the usefulness of salivary diagnostics in the effort to find and fight the disease.

Their results, published by the journal Gastroenterology, are available online at http://dx.doi.org/10.1053/j.gastro.2009.11.010.

Pancreatic ductal adenocarcinoma, the most common type of cancer of the pancreas, is also the most lethal of all cancers, with a mortality rate that is approximately the same as the rate of incidence. The American Cancer Society reports that more than 42,000 people in the United States received a diagnosis of pancreatic cancer in 2009, and the disease caused more than 35,000 deaths. Pancreatic cancer is the fourth leading cause of cancer death in this country. For both men and women, the lifetime risk of developing pancreatic cancer is about one in 72.

A “silent killer,” pancreatic cancer produces its typical symptoms — abdominal pain and jaundice — only in the advanced stage of the disease, making it difficult to fight. Fewer than 5 percent of those diagnosed with the disease live for five years, and full remission is very rare, according to the World Health Organization.

Read full release via UCLA Newsroom.

Read full story via Stabroek News

Earlier this month in Alexandria, U.S. District Judge Anthony Trenga of the Eastern District of Virginia also sentenced Dr. William J. King to three years of supervised release, fined him $20,000 and ordered him to forfeit $150,000 for his involvement in wrongfully prescribing the painkillers.

Read full story via Culpeper Star-Exponent.

Read full story via Medical News Today

The award, which recognizes outstanding contributions to prosthodontics, overall achievement in academic dentistry, and contributions to the sciences or health professions, was presented at the organization’s annual meeting in San Diego.

Campbell has long been a leader in prosthodontics, a dental specialty involving the aesthetic restoration and replacement of teeth, including bridges, crowns, caps, dental implants, dentures, partial dentures, teeth whitening and veneers.

He was influential in modifying the certification program of the American Board of Prosthodontics, and most recently he played an integral role in revising the Commission on Dental Accreditation Standards as they relate to prosthodontics.

Those changes will have a significant impact on the core education students receive while training to be dentists, Campbell said, and will strengthen their preparedness to provide the most appropriate care.

“Over the past several years, prosthodontics has seen a great many changes, and we want to do what is best not only for our patients, but also our students,” he said. One of the revisions in the standards was to ensure that all graduating students are competent in screenings for head and neck cancer.

Campbell has also been instrumental in integrating an evidence-based dental medicine curriculum in the UIC College of Dentistry. The practice applies information from clinical studies to assess the quality of evidence, risks, and benefits of treatments for patients.

“Dental education is preparing a new generation of practitioners who will have the skills to integrate the tools of evidence-based dental medicine into their clinical practice, to foster a commitment to their life-long learning and use it as a life tool,” he said.

Campbell has been at UIC for 17 years, and during that time he has been “an extraordinary leader not only in our college but nationally as well,” said Bruce Graham, dean of the UIC College of Dentistry.

“Steve has consistently encouraged our faculty and me to embrace significant innovations to improve the learning environment of our students,” Graham said. “This award recognizes his tremendous contributions to the field of prosthodontics, and he truly sets the standard for excellence in dental education at UIC.”

For more information about UIC, visit  UIC News Release.

The study, led by Dr. Shiela Strauss, Associate Professor of Nursing and Co-Director of the Statistics and Data Management Core for NYU’s Colleges of Dentistry and Nursing, examined data from 2,923 adult participants in the 2003-2004 National Health and Nutrition Examination Survey who had not been diagnosed with diabetes. The survey, conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention, was designed to assess the health and nutritional status of adults and children in the United States.

Read full story via NYU